MétaCan
Menu
Back to cohort
Record W4244943728 · doi:10.1161/atvb.37.suppl_1.542

Abstract 542: Effects of 1-Methylnicotinamide on Inflammatory and Lipid Biomarkers

2017· article· en· W4244943728 on OpenAlexaff
Jean‐Claude Tardif, Sameh Fikry, Ginette Girard, Tania Discenza, Annik Fortier, Eugenio A. Cefali, Marie‐Claude Guertin

Bibliographic record

VenueArteriosclerosis Thrombosis and Vascular Biology · 2017
Typearticle
Languageen
FieldImmunology and Microbiology
TopicAtherosclerosis and Cardiovascular Diseases
Canadian institutionsMontreal Heart Institute
Fundersnot available
KeywordsMedicineDyslipidemiaInternal medicinePlaceboGastroenterologyQuartileLipid profileRandomized controlled trialC-reactive proteinBlood lipidsCholesterolObesityInflammationConfidence intervalPathology

Abstract

fetched live from OpenAlex

Background: 1-methylnicotinamide, a nicotinic acid metabolite, is TRIA-662’s active component. As part of a pilot study, we assessed TRIA-662’s effects on inflammatory biomarkers and blood lipids. Methods: Patients aged 18-80 years with mean serum triglycerides (TG) 2.26-5.65 mmol/L, low-density lipoprotein-cholesterol levels not needing drug therapy, and stable diet and exercise regimens were randomized to TRIA-662 or placebo (PBO, 3:1) up-titrating to 6 g daily orally for 14 weeks. Outcomes were treatment compliance and changes from baseline in inflammatory biomarkers and blood lipids. Results: The 71 randomized patients were 54±12 years old, 54% were male, 48% were obese, 37% had hypertension, 25% dyslipidemia, and 7% diabetes. Treatment compliance and study completion (95% CI) were reached in 87.1% (79.3, 95.0%) and 87.3% (79.6, 95.1%) of patients overall, respectively. Adjusted geometric mean percent change (95% CI) from baseline in high-sensitivity C-reactive protein was -15.66% (-28.40, -0.66%) with TRIA-662 (p=0.0419 vs baseline) and 1.21% (-13.95, 19.05%) with PBO. The between-group difference of -16.67% (-33.59%, 4.57%) in favor of TRIA-662 did not reach significance (p=0.1130). The effect of TRIA-662 on tumor necrosis factor (TNF) alpha was influenced by the baseline value: For a baseline TNF value of 3.30 pg/mL (third quartile), the adjusted mean change (95% CI) was -0.65 (-0.92, -0.38) pg/mL, corresponding to a 20% decrease, with TRIA-662 and 0.31 (-0.32, 0.95) pg/ml, corresponding to a 9% increase with PBO, with a between-group difference of -0.97 (-1.65, -0.29) pg/mL (p=0.0076). The adjusted mean changes from baseline in adiponectin were 0.55 μg/mL (0.23, 0.86 μg/mL) corresponding to a 6% increase for TRIA-662 and -0.06 μg/mL (-0.53, 0.42 μg/mL) corresponding to a 0.7% decrease for PBO (p=0.0391 between groups). Geometric mean TG value at baseline was 3.36 mmol/L. The adjusted geometric mean percent change (95% CI) in TG was -9.01% (-15.91%, -1.54%) for TRIA-662 and -2.09% (-13.03, 10.24%) for PBO (p=0.3088 between groups). Baseline HDL-C was 1.01 ± 0.28 mmol/L, and the difference in change over time was not significant between groups (p=0.8242). Conclusion: TRIA-662 favourably affected inflammatory biomarkers in this pilot study.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.001
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: none
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.008
Threshold uncertainty score0.027

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0010.001
Meta-epidemiology (narrow)0.0010.000
Meta-epidemiology (broad)0.0010.001
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0010.001
Insufficient payload (model declined to judge)0.0080.001

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.016
GPT teacher head0.254
Teacher spread0.238 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2017
Admission routes1
Has abstractyes

Explore more

Same venueArteriosclerosis Thrombosis and Vascular BiologySame topicAtherosclerosis and Cardiovascular DiseasesFrench-language works237,207